BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pseudomonas infection
,
Prostate
,
Anticancer prodrugs
,
Doxorubicin
,
rs2230926
,
SNCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
USF2_Q6
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Trigeminal ganglia
Spinal cord
Lung
Adrenal gland cortex
Pons
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Vesicular stomatitis Indiana virus disease
COVID-19
Alpha-1-antitrypsin deficiency
Injury of eye region
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CGP 60474
OTS-167
A 443654
flavopiridol
GSK-1059615
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FUBP3
PPP2R2C
NOP2
NR5A1
DROSHA
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
Follicular fluid miRNA profiles during the development of the oocyte
PBMC microRNA expression from pulmonary tuberculosis and sarcoidosis patients
miRNA expression profiles from osteosarcoma samples and cell lines
MicroRNA expression profiling of human adrenal pheochromocytomas
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for USF2_Q6
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for USF2_Q6
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ